A Breast Cancer Research Foundation (BCRF)–AACR NextGen grant honoring Dr. Nancy E. Davidson, supporting mid-career investigators in breast cancer research. This grant empowers an accomplished scientist (typically at associate professor level) to pursue high-risk, high-reward ideas in breast cancer biology or treatment that could markedly advance the field. It is intended to fuel “next generation” breakthroughs by providing substantial, sustained support.
Eligibility Criteria:
- Independent cancer researchers at the level of assistant or associate professor (not full professor) with an established record of impactful research. Typically ≤ 10–12 years since starting independent position.
- Research must be breast cancer–focused, in areas such as tumor biology, genetics/omics, novel therapeutics, prevention, or metastasis. Proposals should outline how the work is innovative and potentially paradigm-shifting in breast cancer understanding or care.
- Applicants must demonstrate productivity (significant publications, prior grants) and leadership in their field, as well as a plan for how this funding will accelerate a transformative project.
- AACR membership is required. Only one application per investigator; no current AACR grant of similar scope.
Funding Details:
- Grant Amount: USD 450,000 over 3 years (disbursed at $150K/year).
- Allowable Costs: Salary/fringe for the PI and team, research supplies, equipment, and limited travel. Indirect costs are capped (usually 0–10% as per AACR policies).
- Grant Term and Expectations: 36 months project period. Progress reports are required. Grantees will present outcomes at an AACR meeting or BCRF symposium, highlighting translational potential of findings.
Deadline:
- Letter of Intent Deadline: December 18, 2025 . (LOI is required and will be peer-reviewed to select finalists.)
- Full Application Deadline (by invite): April 7, 2026 .
- Grant start date: July 1, 2026, with funding spanning 2026–2029.
Where to go for further information: